FerriScan Funding Signals End to Liver Biopsy for Scottish Haemoglobinopathy Patients
- 16 June 2015
The Scottish Paediatric and Adult Haemoglobinopathies Network has secured central funding from the Scottish National Services Directorate for adult patients to access FerriScan R2-MRI (the gold standard measurement of Liver Iron Concentration).
Resonance Health Partners with CSIRO
- 16 June 2015
We are delighted to announce a new collaboration with one of Australia’s leading research organisations; the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to apply their expertise in our product development pipeline.
Advances for Resonance Health in Measurement of Liver Fibrosis
- 09 June 2015
Excitement is building at Resonance Health regarding promising results from a prototype liver fibrosis measurement. The prototype has been demonstrated to distinguish between low and high fibrosis scores in a patient cohort with Hepatitis C.
US study addressing fatty liver disease in children using HepaFat-Scan® technology
- 29 May 2015
We are pleased to announce a collaboration with a prestigious children’s hospital in the USA (Children’s Healthcare of Atlanta) who will perform a validation study of HepaFat-Scan® - our non-invasive medical imaging solution that utilises MRI to accurately measure liver fat.
Prof. Tim St Pierre Presenting at Licnet Conference in Italy
- 07 May 2015
Resonance Health is proudly attending the Licnet (liver Iron Cutino Network) conference - being held on 8th May 2015 in Palermo, Italy:
LIVER DISEASE IN 2015: FROM IRON OVERLOADING TO HEPATITIS C INFECTION MANAGEMENT IN THALASSEMIA
Resonance Health Exhibiting at EASL
- 23 April 2015
Resonance Health is proud to be exhibiting at The 50th International Liver Congress.